Published in J Neurooncol on December 01, 1997
The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther (2008) 1.90
Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res (2004) 1.47
Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol (1999) 1.05
A structural perspective on the regulation of the epidermal growth factor receptor. Annu Rev Biochem (2015) 1.04
Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas. Diagn Pathol (2010) 0.99
Roles for neuregulins in human cancer. Clin Exp Metastasis (2004) 0.98
Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas. Br J Cancer (2004) 0.95
Neuregulin-1 enhances survival of human astrocytic glioma cells. Glia (2005) 0.93
RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling. Neuro Oncol (2012) 0.92
Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor models. Invest New Drugs (2011) 0.78
c-erbB-2 protein expression in astrocytic tumors of the brain. Med Sci Monit (2011) 0.75
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family. Front Cell Dev Biol (2016) 0.75
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
Identification of heregulin, a specific activator of p185erbB2. Science (1992) 4.17
Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology (2001) 3.13
Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science (1989) 3.03
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene (2007) 2.82
The erbB3 gene product is a receptor for heregulin. J Biol Chem (1994) 2.63
The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell (1991) 2.46
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res (2000) 2.24
Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett (1999) 2.06
A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science (1986) 2.06
Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron (1991) 2.03
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A (1997) 1.89
Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci U S A (1995) 1.73
Primary structure and biological activity of a novel human neurotrophic factor. Neuron (1990) 1.65
The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol (1990) 1.64
The rat trkC locus encodes multiple neurogenic receptors that exhibit differential response to neurotrophin-3 in PC12 cells. Neuron (1993) 1.61
The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis (1998) 1.58
Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci U S A (1991) 1.52
Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci (1996) 1.45
Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res (1995) 1.44
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene (1999) 1.39
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
The influence of heregulins on human Schwann cell proliferation. J Neurosci (1995) 1.34
Regulation of the acetylcholine receptor epsilon subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation. Neuron (1995) 1.32
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res (1996) 1.25
Migration of human glioma cells on myelin. Neurosurgery (1996) 1.20
The hypogonadal mouse: reproductive functions restored by gene therapy. Science (1986) 1.20
Karyotype analyses of 20 human glioma cell lines. Acta Neurochir (Wien) (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem (1994) 1.19
Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4. FEBS Lett (1998) 1.17
Functions of agrin and agrin-related proteins. Trends Neurosci (1993) 1.15
CD20: a gene in search of a function. Semin Oncol (2000) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey. Histopathology (2001) 1.13
Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet (1999) 1.12
Regulation of neurotrophin receptor expression during embryonic and postnatal development. J Neurosci (1994) 1.12
Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc Natl Acad Sci U S A (1988) 1.11
Incorporation and distribution of selenium into thiolase from Clostridium kluyveri. J Biol Chem (1985) 1.10
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. Cancer Res (2001) 1.10
Regulation of neurotrophin receptors during the maturation of the mammalian visual system. J Neurosci (1994) 1.10
Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms. Oncogene (2009) 1.09
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Three-dimensional chitin-based scaffolds from Verongida sponges (Demospongiae: Porifera). Part I. Isolation and identification of chitin. Int J Biol Macromol (2010) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci (1992) 1.04
Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis. J Biol Chem (1998) 1.03
The mammalian GnRH gene and its pivotal role in reproduction. Recent Prog Horm Res (1987) 1.03
["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"]. Nervenarzt (2006) 1.02
Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene (1997) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology (1998) 0.98
Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol (1992) 0.96
Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. Am J Respir Cell Mol Biol (2000) 0.95
Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. Oncogene (1999) 0.95
Simultaneous single-step purification of thiolase and NADP-dependent 3-hydroxybutyryl-CoA dehydrogenase from Clostridium kluyveri. Anal Biochem (1984) 0.94
Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells. J Biol Chem (1997) 0.94
Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol (1998) 0.93
Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol (1999) 0.93
The biology of human epidermal growth factor receptor 2. Curr Oncol Rep (1999) 0.92
Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene (1996) 0.92
Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. J Biol Chem (1996) 0.92
Management of spinal dural arteriovenous fistulae using an interdisciplinary neuroradiological/neurosurgical approach: experience with 47 cases. Neurosurgery (1999) 0.92
Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport (1994) 0.91
Purification and immunological studies of selenoprotein A of the clostridial glycine reductase complex. J Biol Chem (1987) 0.91
Surgical treatment of Parkinson's disease. Curr Opin Neurol (1999) 0.91
High-resolution solution structure of the EGF-like domain of heregulin-alpha. Biochemistry (1996) 0.90
A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormone. Nature (1985) 0.90
Neurotrophin gene expression by cell lines derived from human gliomas. J Neurosci Res (1993) 0.89
Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins. J Clin Microbiol (1990) 0.89
alpha-D-glucuronidases from the xylanolytic thermophiles Clostridium stercorarium and Thermoanaerobacterium saccharolyticum. Microbiology (1995) 0.89
A potential role for activated HER-2 in prostate cancer. Semin Oncol (2000) 0.88
Induction of endogenous guinea pig retrovirus by 5-bromodeoxyuridine: amplification of virus-specific RNA. J Virol (1978) 0.87
Tissue- and age-specific expression patterns of alternatively spliced agrin mRNA transcripts in embryonic rat suggest novel developmental roles. J Neurosci (1995) 0.86
Cloning, expression during development, and evidence for release of a trophic factor for ciliary ganglion neurons. Neuron (1992) 0.86
The gene encoding GnRH and its associated peptide GAP: some insights into hypogonadism. J Steroid Biochem (1989) 0.86
Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei. Acta Neurochir (Wien) (2002) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology (2001) 0.86
Activity and biospecificity of proteolyzed forms and dimeric combinations of recombinant human and murine nerve growth factor. J Neurochem (1992) 0.85
A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. J Biol Chem (1999) 0.85
Characterization of neurotrophin receptors by affinity crosslinking. J Neurosci Res (1993) 0.85
Immunocytochemical localization in rat brain of a prolactin release-inhibiting sequence of gonadotropin-releasing hormone prohormone. Nature (1985) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Comparative assessment of the functional p53 status in glioma cells. Anticancer Res (2005) 0.84
Full-length agrin isoform activities and binding site distributions on cultured Xenopus muscle cells. Mol Cell Neurosci (1996) 0.84
"Hybrid" myosin filaments from smooth and striated muscle. J Mol Biol (1976) 0.84
K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3. J Neurochem (1992) 0.84
Human neurocytoma cells in culture show characteristics of astroglial differentiation. J Neurosci Res (1994) 0.84
Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display. J Biol Chem (1998) 0.84
Development of herceptin. Breast Dis (2000) 0.84
Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. Biotechnol Bioeng (2000) 0.83
HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination. Int J Cancer (2001) 0.83
Cyclo-oxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells. Acta Neurochir (Wien) (2002) 0.83